Cargando…

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report

BACKGROUND: Although the BCR-ABL tyrosine kinase inhibitor dasatinib is a potent treatment for chronic myeloid leukaemia, it is associated with the risk of dasatinib-induced pulmonary arterial hypertension (DASA-PAH), for which predisposing factors have yet to be elucidated. However, animal studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toya, Takumi, Nagatomo, Yuji, Kagami, Kazuki, Adachi, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439368/ https://www.ncbi.nlm.nih.gov/pubmed/31020267 http://dx.doi.org/10.1093/ehjcr/ytz025

Ejemplares similares

Friend or foe: food-dependent exercise-induced anaphylaxis associated with acute coronary syndrome aggravated by adrenaline and aspirin: a case report
por: Toya, Takumi, et al.
Publicado: (2019)

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
por: Nishimori, Makoto, et al.
Publicado: (2018)

Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
por: Takatsuka, Ibuki, et al.
Publicado: (2022)

Dasatinib-induced Pulmonary Hypertension
por: Tamura, Yudai, et al.
Publicado: (2022)

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
por: Skride, Andris, et al.
Publicado: (2017)

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
por: Jose, Arun, et al.
Publicado: (2017)

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
por: Hong, Ji Hyung, et al.
Publicado: (2015)

Sarco/Endoplasmic Reticulum Ca(2+) ATPase 2 Activator Ameliorates Endothelial Dysfunction; Insulin Resistance in Diabetic Mice
por: Kimura, Toyokazu, et al.
Publicado: (2022)

Coronary microvascular dysfunction in heart failure patients
por: Toya, Takumi, et al.
Publicado: (2023)

Pulmonary arterial hypertension in scleroderma: care gaps in screening
por: Pope, Janet E.
Publicado: (2017)

Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the Pathology of Heart Failure
por: Yukino-Iwashita, Midori, et al.
Publicado: (2022)

Reactive Oxygen Species in the Aorta and Perivascular Adipose Tissue Precedes Endothelial Dysfunction in the Aorta of Mice with a High-Fat High-Sucrose Diet and Additional Factors
por: Osaki, Ayumu, et al.
Publicado: (2023)

Endothelial Extracellular Signal‐Regulated Kinase/Thromboxane A2/Prostanoid Receptor Pathway Aggravates Endothelial Dysfunction and Insulin Resistance in a Mouse Model of Metabolic Syndrome
por: Sato, Atsushi, et al.
Publicado: (2022)

Non-traumatic Acute Subdural Hematoma in a Patient With Scleroderma Complicated by Pulmonary Arterial Hypertension: A Case Report
por: Evbayiro, Uyioghosa, et al.
Publicado: (2023)

D-Dimer beyond Diagnosis of Pulmonary Embolism: Its Implication for Long-Term Prognosis in Cardio-Oncology Era
por: Himeno, Masafumi, et al.
Publicado: (2023)

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
por: Seegobin, Karan, et al.
Publicado: (2017)

Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose
por: Kubota, Kana, et al.
Publicado: (2022)

Borderline pulmonary pressures in scleroderma - a ‘pre-pulmonary arterial hypertension’ condition?
por: Kovacs, Gabor, et al.
Publicado: (2015)

Limited Scleroderma-Induced Pulmonary Arterial Hypertension Resulting in Impaired Postoperative Respiratory Function
por: Shah, Farhan A, et al.
Publicado: (2021)

Localized scleroderma with pulmonary arterial hypertension and pulmonary interstitial fibrosis in a patient with positive Th/to antibodies: Case report and review of literature
por: Elinkichari, Dorsaf, et al.
Publicado: (2023)

Dasatinib-induced hemorrhagic colitis complicated with cytomegalovirus infection
por: Nakaya, Aya, et al.
Publicado: (2017)

The frequency of pulmonary hypertension in juvenile scleroderma
por: Adrovic, Amra, et al.
Publicado: (2014)

Association between Smoking and Urine Indole Levels Measured by a Commercialized Test
por: Mine, Masataka, et al.
Publicado: (2022)

Impact of oxidative posttranslational modifications of SERCA2 on heart failure exacerbation in young patients with non-ischemic cardiomyopathy: A pilot study
por: Toya, Takumi, et al.
Publicado: (2019)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
por: El-Dabh, Ashraf, et al.
Publicado: (2019)

Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension
por: Sugino, Keishi, et al.
Publicado: (2018)

Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations
por: Schwaiger, Johannes P., et al.
Publicado: (2013)

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018)

Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma
por: Ketpueak, Thanika, et al.
Publicado: (2022)

Change of right ventricular systolic pressure can indicate dasatinib‐induced pulmonary arterial hypertension in chronic myeloid leukemia
por: Lee, Sung‐Eun, et al.
Publicado: (2021)

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
por: Hennigs, Jan K, et al.
Publicado: (2011)

A Low Arginine/Ornithine Ratio is Associated with Long-Term Cardiovascular Mortality
por: Ishinoda, Yuki, et al.
Publicado: (2023)

Dasatinib for treatment of CAR T-cell therapy-related complications
por: Baur, Katharina, et al.
Publicado: (2022)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Iron therapy as a novel treatment of scleroderma‐related pulmonary hypertension: A case report and literature review
por: Neumann, Melissa, et al.
Publicado: (2022)

Pulmonary Artery Dissection: A Fatal Complication of Pulmonary Hypertension
por: Zhang, Chuanchen, et al.
Publicado: (2016)

Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases
por: Bellan, Mattia, et al.
Publicado: (2021)

Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib
por: Takekoshi, Daisuke, et al.
Publicado: (2020)

Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report
por: Ochiai, Shoko, et al.
Publicado: (2019)

Pulmonary hypertension complicating unilateral absence of pulmonary artery and coronary‐pulmonary artery fistula: Report of a case and review of the literature
por: Lin, Chen‐Chieh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sahve1ugfua743a176fhlto9p5